Cargando…
Asthma exacerbations during the pandemic: Time to rethink clinical markers
BACKGROUND: Reductions in asthma exacerbations during the coronavirus disease 2019 (COVID-19) pandemic may have an impact on clinical trial enrollment and outcomes. OBJECTIVE: Our aim was to review clinical studies and reports evaluating asthma exacerbations before and during the COVID-19 pandemic....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581642/ https://www.ncbi.nlm.nih.gov/pubmed/36281240 http://dx.doi.org/10.1016/j.jacig.2022.09.003 |